Open·Ingested 90 days ago, not re-verified since

DoW Peer Reviewed Cancer, Clinical Trial Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Free. Verify your email, then we send one reminder only.

Download details (file)

Posted: May 6, 2026
Amount: $45,000,000
Closes: Oct 5, 2026 (in 62 days)

Similar opportunities open now

DoW Peer Reviewed Medical, Clinical Trial AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 49 days
DoW, Peer Reviewed Cancer, Impact AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 62 days
DoW Peer Reviewed Cancer, Idea AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 62 days
DoW Peer Reviewed Medical, Impact AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 2 days
DoW Peer Reviewed Medical, Lifestyle and Applied Health Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 2 days

Classification and identifiers

Solicitation number: HT942526PRCRPCTA
Assistance listing (CFDA): 12.420

Amount

$45,000,000

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of cancer within at least one of the FY26 PRCRP Topic Areas. Clinical trials proposed may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) that evaluate the effects of interventions or inform the design of more advanced trials to large-scale trials (up to phase III) to determine efficacy in relevant patient populations. Distinctive Features: • Applicatio...